Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

139.11
+1.120.81%
Volume:15.07M
Turnover:2.12B
Market Cap:55.54B
PE:-17.37
High:144.20
Open:134.10
Low:133.86
Close:137.99
52wk High:176.66
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:0.52
T/O Rate:4.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:8.21
PE(LYR):-19.16

Loading ...

Moderna Shares Rise After Wolfe Research Upgrade

MT Newswires Live
·
Aug 26

Moderna Stock Gains as Melanoma Vaccine Results De-Risk Approach

Dow Jones
·
Aug 26

Moderna rises 13.0%

TIPRANKS
·
Aug 26

Moderna Stock (MRNA) Rises 12.5% Today Following Phase 3 mRNA Cancer Vaccine Win with Merck

TIPRANKS
·
Aug 26

Top Calls On Wall Street: Nvidia, AMD, SpaceX, Netflix, Dell, Coinbase, Moderna, Strategy, and More

Tiger Newspress
·
Aug 25

Moderately bullish activity in Moderna with shares up 11.44%

TIPRANKS
·
Aug 25

Moderna Raised to Peer Perform from Underperform by Wolfe Research

Dow Jones
·
Aug 25

What Happens if Moderna's Cancer Vaccine Works

Dow Jones
·
Aug 25

Market Movers | Bloom Energy Rises on Pelosi Buy; Nebius, NetEase Gain on Goldman Calls; Moderna Rallies

Tiger Newspress
·
Aug 25

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
Aug 25

Moderna on Track for Best Month on Record

Dow Jones
·
Aug 25

Early notable gainers among liquid option names on August 25th

TIPRANKS
·
Aug 25

Moderna Shares up 8.4% as Barclays Hikes Price Target

THOMSON REUTERS
·
Aug 25

Movement Alert|Moderna, Inc. Rises 4.3% in Regular Trading, Continued Price Reassessment After Cancer Vaccine Phase III Success

Market Focus
·
Aug 25

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday as Chip Stocks Recover

MT Newswires Live
·
Aug 25

After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)

TIPRANKS
·
Aug 25

Moderna upgraded to Peer Perform from Underperform at Wolfe Research

TIPRANKS
·
Aug 25

Movement Alert|Moderna, Inc. Rises 3.99% in Pre-Market Trading, Continues Volatile Re-Rating After mRNA Cancer Vaccine Phase III Success

Market Focus
·
Aug 25

Binance launches 5 stock perpetuals with 20x leverage

cryptonews
·
Aug 25

Moderna's Landmark mRNA Cancer Vaccine Trial Success Ignites Biotech Sector Rally, Valuation Reset May Be Just Beginning

Stock News
·
Aug 25